Evidence map›Paper›PMID 32416028›Full record

ReviewEuropean journal of neurology2020

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.

K Vonck, I Garrez, V De Herdt, D Hemelsoet, G Laureys, R Raedt, P Boon

Open access · greenAbstract readReview
In one paragraph

Review in European journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 4 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 4 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Neurological complications caused by SARS-CoV-2.Clinical microbiology reviews · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Healthcare Innovations to Address the Challenges of the COVID-19 Pandemic.IEEE journal of biomedical and health informatics · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

K VonckDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0002-2671-2650
I GarrezDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0003-2190-0799
V De HerdtDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0003-4672-4752
D HemelsoetDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0001-5403-3092
G LaureysDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0002-1708-4373
R RaedtDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0002-8939-0169
P BoonDepartment of Neurology, 4Brain, Ghent University Hospital, Gent, Belgium.ORCID 0000-0002-4180-8896
Ghent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeInfections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported. The aim of this study was to perform a review to describe neurological manifestations in patients with COVID-19 and possible neuro-invasive mechanisms of Sars-CoV-2.

methodsPubMed, Web of Science and COVID-dedicated databases were searched for the combination of COVID-19 terminology and neurology terminology up to 10 May 2020. Social media channels were followed up between 15 March and 10 May 2020 for postings with the same scope. Neurological manifestations were extracted from the identified papers and combined to provide a useful summary for the neurologist in clinical practice.

resultsNeurological manifestations potentially related to COVID-19 have been reported in large studies, case series and case reports and include acute cerebrovascular diseases, impaired consciousness, cranial nerve manifestations and autoimmune disorders such as the Guillain-Barré syndrome often present in patients with more severe COVID-19. Cranial nerve symptoms such as olfactory and gustatory dysfunctions are highly prevalent in patients with mild to moderate COVID-19 even without associated nasal symptoms and often present in an early stage of the disease.

conclusionPhysicians should be aware of the neurological manifestations in patients with COVID-19, especially when rapid clinical deterioration occurs. The neurological symptoms in COVID-19 patients may be due to direct viral neurological injury or indirect neuroinflammatory and autoimmune mechanisms. No antiviral treatments against the virus or vaccines for its prevention are available and the long-term consequences of the infection on human health remain uncertain especially with regard to the neurological system.

Indexed as

AnimalsCoronavirus InfectionsCOVID-19HumansNervous SystemNervous System DiseasesPandemicsPneumonia, Viralcerebrovascular diseasesCOVID-19neuro-invasive mechanismneurological manifestationsSARS-CoV-2

Identifiers

PMID32416028
PMCPMC7276727
OpenAlexW3024442031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.